Ofer Daphna News Today : Breaking News, Live Updates & Top Stories | Vimarsana

EyeYon Medical Receives CE Mark for its EndoArt® Implant to Treat Chronic Corneal Edema Font : A-A+ EndoArt® previously received Innovative Device Status by the Chinese NMPA, and Breakthrough Device Designation from the US Food and Drug Administration TEL AVIV, Israel, June 8, 2021 /PRNewswire/ -- EyeYon Medical, an Israeli start-up company developing a variety of ophthalmic products for vision-threatening conditions, announced today that it has received CE Mark for its EndoArt®, after clinical trials demonstrated safety and efficacy for treating chronic corneal edema. The CE Mark ser...

Israeli cornea treatment co EyeYon raises $25m The Israeli company will use the capital to expand clinical trials to treat corneal endema. Israeli medical device company EyeYon Medical EyeYon Medical today announced the completion of a $25 million Series C financing round, led by a global strategic leader in the ophthalmic industry and CR-CP Life Science Fund, together with Global Health Sciences (GHS) Fund (Quark Venture LP and GF Securities), BPC and existing investors Triventures, Rimonci, Pontifax and Diamond BioFund. The latest round brings the total amount of capital raised by the compa...

EyeYon Medical Raises $25 million in Series C to Transform Corneal Care USA - English News provided by Share this article Share this article TEL AVIV, Israel, March 15, 2021 /PRNewswire/ -- EyeYon Medical announced today the completion of a $25 million in a Series C funding, led by a global strategic leader in the ophthalmic industry and CR-CP Life Science Fund. Other participants in the round include Global Health Sciences (GHS) Fund (Quark Venture LP and GF Securities), BPC and existing investors Triventures, Rimonci, Pontifax and Diamond BioFund. EyeYon Medical was founded in 2011 by Dr. ...